This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 21-24, 2020
Proudly part of BioPharm AmericaDelivered Digitally | US Eastern Daylight Time

Keith Horspool, PhD
Vice President Pharmaceutics at Boehringer Ingelheim


Keith is Vice President of External Alternative CMC Development (EACD) at BI. EACD operates as a “biotech within pharma” using an integrated network of virtual resources to deliver all CMC requirements for projects, applying alternative development approaches for NCEs and NCE‐like new modalities. Prior to joining BI, Keith worked at Pfizer and AstraZeneca. He has worked in Pharma for more than 30 years with experience managing preformulation, product development, drug delivery and materials science. Keith has diverse experience with a broad range of delivery systems and various routes of delivery, particularly oral, inhalation and parenteral delivery.

Keith Horspool, PhD's Network

Agenda Sessions

  • Chairperson's Opening Remarks

  • Panel Discussion: Exploring Partnerships and Industry Success in 2020 and Beyond